 |
 |
 |
 |
Development of Genetic Tools for Analysis of Streptococcus sanguinis
L.S. TURNER, S. DAS, T. KANAMOTO, C.L. MUNRO, and T. KITTEN, Virginia Commonwealth University - VCU/MCV, Richmond, USA | Objectives: Streptococcus sanguinis is a member
of the normal oral flora and a common cause of infective endocarditis (IE). Completion
of the genome sequence of S. sanguinis SK36 necessitates tools for further
characterization of this species. It is often desirable to insert antibiotic
resistance markers and other exogenous genes into the chromosome; therefore, we
sought to identify a chromosomal site for ectopic expression of foreign genes,
and verify that insertion into this site did not affect important cellular
phenotypes. Methods: An erm resistance gene controlled by a
synthetic promoter was cloned into a genomic region encoding only a small (65aa)
hypothetical protein to create strain JFP36. To determine whether this
insertion affected important cellular properties, SK36 and JFP36 were compared
for: (i) growth, by measuring growth curves in a microplate reader; (ii)
competence, by measuring transformation frequency and efficiency; (iii)
biofilm formation using a standard crystal violet staining assay; and (iv)
virulence for endocarditis in the rabbit model of IE. Results: Insertion
of erm did not affect growth or competence of JFP36. Average transformation
frequencies for JFP36 and SK36 were 27.13% and 27.38%, respectively, while
transformation efficiencies were 8.25x107 and 8.6 x107 CFU/µg
DNA. Biofilm formation of both strains was similar whether glucose (P=0.2464)
or sucrose (P=0.1145) was provided as a carbon source. Virulence in the
rabbit model of IE, as assessed by recovery of bacteria from heart valves of
co-inoculated rabbits, was similar (P=0.5237), indicating that virulence
was not significantly affected. Conclusions: Our results suggest that insertion
of the erm gene does not alter in vitro or in vivo phenotypes
that typify S. sanguinis SK36; therefore, this chromosomal site is a
good candidate for further manipulations of S. sanguinis. We are
currently developing strains with other alterations in this region. Supported
by NIH grants R01AI47841 and K02AI054908 (TK).
|
Seq #41 - AADR/Johnson & Johnson Oral Health Products Hatton Awards - Senior Category 1:30 PM-2:30 PM, Thursday, April 3, 2008 Hilton Anatole Hotel Trinity I - Exhibit Hall |
Back to the AADR/Johnson & Johnson Oral Health Products Hatton Awards Program
|
|